EP2475667A1 — Inhibitors of jak
Assigned to F Hoffmann La Roche AG · Expires 2012-07-18 · 14y expired
What this patent protects
The present invention relates to the use of novel compounds of Formula (I), (I) wherein the variables m, n, p, q, Q, r, R, R', X, X', Y, Z 1 , Z 2 , and Z 3 are defined as described herein, which inhibit JAK and are useful for the treatment of auto-immune and inflammatory diseas…
USPTO Abstract
The present invention relates to the use of novel compounds of Formula (I), (I) wherein the variables m, n, p, q, Q, r, R, R', X, X', Y, Z 1 , Z 2 , and Z 3 are defined as described herein, which inhibit JAK and are useful for the treatment of auto-immune and inflammatory diseases.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.